Error: Could not add to watchlist. X
+ Watchlist

Akela Pharma Inc

AKL:CN
Ticker Delisted
CAD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.36
Market Cap (CAD)
-
Shares Outstanding (m)
32.390
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.35%
% Price Change
+0.33%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Akela Pharma, Inc. researches and develops treatments for cancer pain, asthma, chronic obstructive pulmonary disease, and growth hormone deficiencies.
Address
11501 Domain Drive
Suite 130
Austin, TX 78758
United States
Phone
1-512-834-0449
Show More